-
1دورية أكاديمية
المؤلفون: Pfeiler, Georg, Hlauschek, Dominik, Mayer, Erica L., Deutschmann, Christine, Kacerovsky-Strobl, Stephanie, Martin, Miguel, Meisel, Jane Lowe, Zdenkowski, Nicholas, Loibl, Sibylle, Balic, Marija, Park, Haeseong, Prat, Aleix, Isaacs, Claudine, Bajetta, Emilio, Balko, Justin M., Bellet-Ezquerra, Merixtell, Bliss, Judith, Burstein, Harold, Cardoso, Fatima, Fohler, Hannes
المصدر: Journal of Clinical Oncology; 11/20/2023, Vol. 41 Issue 2, p5118-5130, 18p
-
2دورية أكاديمية
المؤلفون: Li, Xuanyi, Park, Ben Ho, Balko, Justin M., Johnson, Douglas Buckner
المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3138-3138, 1p
-
3دورية أكاديمية
المؤلفون: Castellanos, Emily H., Feld, Emily, Estrada, Monica V., Sanders, Melinda E., Massion, Pierre P., Johnson, Douglas B., Balko, Justin M., Horn, Leora
المصدر: JCO Precision Oncology; 2017, Vol. 1 Issue 1, p1-9, 9p
مصطلحات موضوعية: NON-small-cell lung carcinoma, AXILLARY lymph node dissection
مستخلص: After his initial disease progression while receiving anti-PD-L1 therapy, repeat biopsy demonstrated no tumor PD-L1 staining (with limited stromal PD-L1 positivity), and PD-L2 remained strongly positive (70%; Fig 1C). This finding suggests that the significance of PD-L2 positivity in response to PD-L1 or PD-1 targeted therapies may be a useful subject of study. Although anecdotal, this case report demonstrates an important clinical finding: patients who become resistant to anti-PD-L1 may still benefit from PD-1 targeted therapies, possibly due to a switch from dependency on PD-L1 to PD-L2 for maintenance of immunosuppression. However, the presence of consistently high PD-L2 staining argues against a direct mechanism of PD-L2-mediated de novo resistance to anti-PD-L1 therapy. [Extracted from the article]
: Copyright of JCO Precision Oncology is the property of American Society of Clinical Oncology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
-
4دورية أكاديمية
المؤلفون: DeMichele, Angela, Dueck, Amylou C., Hlauschek, Dominik, Martin, Miguel, Burstein, Harold J., Pfeiler, Georg, Zdenkowski, Nicholas, Wolff, Antonio C., Balic, Marija, Miller, Kathy, Cameron, David A., Balko, Justin M., Traina, Tiffany A., Czajkowska, Dorota, Metzger, Otto, Lu, Dongrui Ray, O'Brien, Patrick, Fesl, Christian, Mayer, Erica L., Gnant, Michael
المصدر: Journal of Clinical Oncology; 10/20/2022 Supplement 36, Vol. 40, p390216-390216, 1p
-
5دورية أكاديمية
المؤلفون: Mayer, Ingrid A, Abramson, Vandana G, Isakoff, Steven J, Forero, Andres, Balko, Justin M, Kuba, María Gabriela, Sanders, Melinda E, Yap, Jeffrey T, Van den Abbeele, Annick D, Li, Yisheng, Cantley, Lewis C, Winer, Eric, Arteaga, Carlos L
المصدر: Journal of Clinical Oncology; 4/20/2014, Vol. 32 Issue 12, p1202-1209, 8p
-
6دورية أكاديمية
المؤلفون: Mayer, Ingrid A., Abramson, Vandana G., Isakoff, Steven J., Forero, Andres, Balko, Justin M., Kuba, María Gabriela, Sanders, Melinda E., Yap, Jeffrey T., Van den Abbeele, Annick D., Yisheng Li, Cantley, Lewis C., Winer, Eric, Arteaga, Carlos L.
المصدر: Journal of Clinical Oncology; 4/20/2014, Vol. 32 Issue 12, p1202-1209, 9p
-
7دورية أكاديمية
المؤلفون: Miller, Todd W., Balko, Justin M., Arteaga, Carlos L.
المصدر: Journal of Clinical Oncology; 11/20/2011, Vol. 29 Issue 33, p4452-4461, 10p